![Rhonda Chicko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rhonda Chicko
Plus aucun poste en cours
Fortune : 13 152 $ au 31/08/2026
Profil
Rhonda M.
Chicko currently works at Cyclerion Therapeutics, Inc., as Chief Financial Officer.
Ms. Chicko also formerly worked at Ironwood Pharmaceuticals, Inc., as Senior Director-Finance & Tax from 2005 to 2015, Wellington Management Co. LLP, as Controller, Editas Medicine, Inc., as Vice President-Finance from 2015 to 2018, and Scholar Rock Holding Corp., as Chief Financial & Accounting Officer from 2018 to 2019.
Ms. Chicko received her graduate degree from Bentley University and undergraduate degree from Le Moyne College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,01 % | 14/08/2026 | 3 574 ( 0,01 % ) | 13 152 $ | 31/08/2026 |
Anciens postes connus de Rhonda Chicko
| Sociétés | Poste | Fin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Financier/CFO | 30/09/2019 |
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 03/01/2018 |
| IRONWOOD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/01/2015 |
| CYCN THERNPV | Directeur Financier/CFO | - |
Wellington Management Co. LLP
 Wellington Management Co. LLP Investment ManagersFinance WMC relies on their extensive independent research and includes portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has several different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. | Comptroller/Controller/Auditor | - |
Formation de Rhonda Chicko
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Wellington Management Co. LLP
Wellington Management Co. LLP Investment ManagersFinance WMC relies on their extensive independent research and includes portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has several different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. | Finance |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Le Moyne College
 Le Moyne College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
